SCHEMBL1059438

SCHEMBL1059438

CC(C#N)OP(Cl)N(C(C)C)C(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8741525 1.00
SCHEMBL1061644 0.80
SCHEMBL887785 0.77 TSHR (0.30)
SCHEMBL1060663 0.77 TSHR (0.30)
SCHEMBL10632508 0.74
SCHEMBL2953096 0.72
SCHEMBL25408699 0.68
SCHEMBL13086080 0.68
SCHEMBL25146 0.68
SCHEMBL2384813 0.68 TSHR (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2647713-B1 MODIFIED SINGLE-STRAND POLYNUCLEOTIDE DAIICHI SANKYO CO LTD (JP) 2018-02-21 EP claimed
US-8987226-B2 Modified single-stranded polynucleotides DAIICHI SANKYO COMPANY, LIMITED (JP) 2015-03-24 US claimed
EP-2647713-A1 MODIFIED SINGLE-STRAND POLYNUCLEOTIDE DAIICHI SANKYO COMPANY, LIMITED (JP) 2013-10-09 EP claimed
US-20130253038-A1 Modified Single-Stranded Polynucleotide DAIICHI SANKYO COMPANY, LIMITED (JP) 2013-09-26 US claimed
EP-0684954-B1 NUCLEIC ACID PROBES CHEMICALLY 5'(OH)- AND/OR 3'(OH)-MODIFIED FOR INSERTING ONE OR MORE NON-RADIOACTIVE LABELING ELEMENTS THEREAT, AND METHOD FOR PREPARING SAME WALLONE REGION (BE) 1998-07-22 EP claimed
EP-0684954-A1 NUCLEIC ACID PROBES CHEMICALLY 5'(OH)- AND/OR 3'(OH)-MODIFIED FOR INSERTING ONE OR MORE NON-RADIOACTIVE LABELING ELEMENTS THEREAT, AND METHOD FOR PREPARING SAME LA REGION WALLONNE (BE) 1995-12-06 EP claimed
WO-1994019364-A2 NUCLEIC ACID PROBES CHEMICALLY 5'(OH)- AND/OR 3'(OH)-MODIFIED FOR INSERTING ONE OR MORE NON-RADIOACTIVE LABELING ELEMENTS THEREAT, AND METHOD FOR PREPARING SAME LA REGION WALLONNE (BE) 1994-09-01 WO claimed
US-5218102-A Easily synthesized, hybridize well with target sequences IMPROBIO (BE) 1993-06-08 US claimed
WO-2025264952-A2 NOVEL RNA THERAPEUTICS AND USES THEREOF ELI LILLY AND COMPANY (US) 2025-12-26 WO disclosed
WO-2025063239-A1 SIRNA CAPABLE OF SUPPRESSING EXPRESSION OF α-SYNUCLEIN 第一三共株式会社 2025-03-27 WO disclosed
WO-2025063238-A1 SIRNA FOR SUPPRESSING EXPRESSION OF PHOSPHOLAMBAN 第一三共株式会社 2025-03-27 WO disclosed
EP-4373829-A1 PROCESS FOR PREPARATION OF TARGETING LIGANDS Janssen Pharmaceuticals, Inc. (US) 2024-05-29 EP disclosed
EP-4153604-A1 OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF Wave Life Sciences Ltd. (SG) 2023-03-29 EP disclosed
WO-2023002452-A1 PROCESS FOR PREPARATION OF TARGETING LIGANDS Janssen Pharmaceuticals, Inc. (US) 2023-01-26 WO disclosed
US-5082934-A COUMARIN DERIVATIVES FOR USE AS NUCLEOTIDE CROSSLINKING REAGENTS NAXCOR (US) 1992-01-21 US disclosed
US-5013830-A Genetic engineering AJINOMOTO CO., INC. (JP) 1991-05-07 US disclosed
WO-1990012020-A1 COUMARIN DERIVATIVES FOR USE AS NUCLEOTIDE CROSSLINKING REAGENTS NAXCOR (US) 1990-10-18 WO disclosed
EP-0334694-A1 Nucleic acid probes with non-radioactive labels, and preparation processes LA REGION WALLONNE (BE) 1989-09-27 EP disclosed
EP-0260032-A2 Compounds for the cleavage at a specific position of RNA, oligomers employed for the formation of said compounds, and starting materials for the synthesis of said oligomers AJINOMOTO CO., INC. (JP) 1988-03-16 EP disclosed
EP-0196101-A2 Purification of synthetic oligomers CHIRON CORPORATION (US) 1986-10-01 EP disclosed